India Authority Clears CIPL Merger With IPC
This article was originally published in PharmAsia News
Executive Summary
The proposed merger of Central India Pharmacopoeia Laboratory with Indian Pharmacopoeia Commission won the approval of Indian authorities. The Union Cabinet also approved staff, asset and liability transfers from CIPL to IPC. The approval enables the pre-merger IPC to continue to function in advance of the actual merger with CIPL. (Click here for more